|
1
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steinwascher S, Nugues AL, Schoeneberger H
and Fulda S: Identification of a novel synergistic induction of
cell death by Smac mimetic and HDAC inhibitors in acute myeloid
leukemia cells. Cancer Lett. 366:32–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tamm I, Kornblau SM, Segall H, Krajewski
S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, et al:
Expression and prognostic significance of IAP-family genes in human
cancers and myeloid leukemias. Clin Cancer Res. 6:1796–1803.
2000.PubMed/NCBI
|
|
4
|
Zeng H, Chen W, Zheng R, Zhang S, Ji JS,
Zou X, Xia C, Sun K, Yang Z, Li H, et al: Changing cancer survival
in China during 2003-15: A pooled analysis of 17 population-based
cancer registries. Lancet Glob Health. 6:e555–e567. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Long L, Assaraf YG, Lei ZN, Peng H, Yang
L, Chen ZS and Ren S: Genetic biomarkers of drug resistance: A
compass of prognosis and targeted therapy in acute myeloid
leukemia. Drug Resist Updat. 52:1007032020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murphy T and Yee KWL: Cytarabine and
daunorubicin for the treatment of acute myeloid leukemia. Expert
Opin Pharmacother. 18:1765–1780. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DiNardo CD, Pratz K, Pullarkat V, Jonas
BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH,
Kantarjian HM, et al: Venetoclax combined with decitabine or
azacitidine in treatment-naive, elderly patients with acute myeloid
leukemia. Blood. 133:7–17. 2019. View Article : Google Scholar :
|
|
8
|
Carter JL, Hege K, Yang J, Kalpage HA, Su
Y, Edwards H, Hüttemann M, Taub JW and Ge Y: Targeting multiple
signaling pathways: The new approach to acute myeloid leukemia
therapy. Signal Transduct Target Ther. 5:2882020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia X, Wang X, Cheng Z, Qin W, Lei L,
Jiang J and Hu J: The role of pyroptosis in cancer: Pro-cancer or
pro-'host'? Cell Death Dis. 10:6502019. View Article : Google Scholar
|
|
10
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the Nomenclature Committee on Cell Death. 2018.Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding J, Wang K, Liu W, She Y, Sun Q, Shi
J, Sun H, Wang DC and Shao F: Pore-forming activity and structural
autoinhibition of the gasdermin family. Nature. 535:111–116. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuang S, Zheng J, Yang H, Li S, Duan S,
Shen Y, Ji C, Gan J, Xu XW and Li J: Structure insight of GSDMD
reveals the basis of GSDMD autoinhibition in cell pyroptosis. Proc
Natl Acad Sci USA. 114:10642–10647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Gao W, Shi X, Ding J, Liu W, He H,
Wang K and Shao F: Chemotherapy drugs induce pyroptosis through
caspase-3 cleavage of a gasdermin. Nature. 547:99–103. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang YY, Liu XL and Zhao R: Induction of
pyroptosis and its implications in cancer management. Front Oncol.
9:9712019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rogers C, Fernandes-Alnemri T, Mayes L,
Alnemri D, Cingolani G and Alnemri ES: Cleavage of DFNA5 by
caspase-3 during apoptosis mediates progression to secondary
necrotic/pyroptotic cell death. Nat Commun. 8:141282017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson DC, Taabazuing CY, Okondo MC, Chui
AJ, Rao SD, Brown FC, Reed C, Peguero E, de Stanchina E, Kentsis A
and Bachovchin DA: DPP8/DPP9 inhibitor-induced pyroptosis for
treatment of acute myeloid leukemia. Nat Med. 24:1151–1156. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang W, Liu S, Li Y, Wang Y, Deng Y, Sun
W, Huang H, Xie J, He A, Chen H, et al: Pyridoxine induces
monocyte-macrophages death as specific treatment of acute myeloid
leukemia. Cancer Lett. 492:96–105. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Zhang Y and Lieberman J: Lighting
a fire: Can we harness pyroptosis to ignite antitumor immunity?
Cancer Immunol Res. 9:2–7. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang M, Qi L, Li L and Li Y: The
caspase-3/GSDME signal pathway as a switch between apoptosis and
pyroptosis in cancer. Cell Death Discov. 6:1122020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klionsky DJ, Petroni G, Amaravadi RK,
Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K,
Cecconi F, Choi AMK, et al: Autophagy in major human diseases. EMBO
J. 40:e1088632021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang R, Xu J, Zhang B, Liu J, Liang C, Hua
J, Meng Q, Yu X and Shi S: Ferroptosis, necroptosis, and pyroptosis
in anticancer immunity. J Hematol Oncol. 13:1102020. View Article : Google Scholar :
|
|
23
|
Galluzzi L and Green DR:
Autophagy-independent functions of the autophagy machinery. Cell.
177:1682–1699. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Frank D and Vince JE: Pyroptosis versus
necroptosis: Similarities, differences, and crosstalk. Cell Death
Differ. 26:99–114. 2019. View Article : Google Scholar
|
|
25
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klobucar K, Côté JP, French S, Borrillo L,
Guo ABY, Serrano-Wu MH, Lee KK, Hubbard B, Johnson JW, Gaulin JL,
et al: Chemical screen for vancomycin antagonism uncovers probes of
the gram-negative outer membrane. ACS Chem Biol. 16:929–942. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lozzio CB and Lozzio BB: Human chronic
myelogenous leukemia cell-line with positive Philadelphia
chromosome. Blood. 45:321–334. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pertea M, Pertea GM, Antonescu CM, Chang
TC, Mendell JT and Salzberg SL: StringTie enables improved
reconstruction of a transcriptome from RNA-seq reads. Nat
Biotechnol. 33:290–295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gene Ontology Consortium: Gene ontology
consortium: Going forward. Nucleic Acids Res. 43(Database Issue):
D1049–D1056. 2015. View Article : Google Scholar :
|
|
31
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T
and Yamanishi Y: KEGG for linking genomes to life and the
environment. Nucleic Acids Res. 36(Database Issue): D480–D484.
2008. View Article : Google Scholar :
|
|
32
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). method Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
34
|
Zhao X, Zhu L, Liu D, Chi T, Ji X, Liu P,
Yang X, Tian X and Zou L: Sigma-1 receptor protects against
endoplasmic reticulum stress-mediated apoptosis in mice with
cerebral ischemia/reperfusion injury. Apoptosis. 24:157–167. 2019.
View Article : Google Scholar
|
|
35
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View Article : Google Scholar
|
|
36
|
Lai L, Shin GY and Qiu H: The role of cell
cycle regulators in cell survival-dual functions of
cyclin-dependent kinase 20 and p21Cip1/Waf1. Int J Mol
Sci. 21:85042020. View Article : Google Scholar
|
|
37
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar
|
|
38
|
Nicholson DW, Ali A, Thornberry NA,
Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle
M, Lazebnik YA, et al: Identification and inhibition of the
ICE/CED-3 protease necessary for mammalian apoptosis. Nature.
376:37–43. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kavanagh E, Rodhe J, Burguillos MA, Venero
JL and Joseph B: Regulation of caspase-3 processing by cIAP2
controls the switch between pro-inflammatory activation and cell
death in microglia. Cell Death Dis. 5:e15652014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cohen GM: Caspases: The executioners of
apoptosis. Biochem J. 326(Pt 1): 1–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Carneiro BA and El-Deiry WS: Targeting
apoptosis in cancer therapy. Nat Rev Clin Oncol. 17:395–417. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nikoletopoulou V, Markaki M, Palikaras K
and Tavernarakis N: Crosstalk between apoptosis, necrosis and
autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Oakes SA and Papa FR: The role of
endoplasmic reticulum stress in human pathology. Annu Rev Pathol.
10:173–194. 2015. View Article : Google Scholar
|
|
44
|
Bortner CD and Cidlowski JA: Ions, the
movement of water and the apoptotic volume decrease. Front Cell Dev
Biol. 8:6112112020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saliba AN, John AJ and Kaufmann SH:
Resistance to venetoclax and hypomethylating agents in acute
myeloid leukemia. Cancer Drug Resist. 4:125–142. 2021.PubMed/NCBI
|
|
46
|
Blombery P: Mechanisms of intrinsic and
acquired resistance to venetoclax in B-cell lymphoproliferative
disease. Leuk Lymphoma. 61:257–262. 2020. View Article : Google Scholar
|
|
47
|
Vanden Berghe T, Vanlangenakker N,
Parthoens E, Deckers W, Devos M, Festjens N, Guerin CJ, Brunk UT,
Declercq W and Vandenabeele P: Necroptosis, necrosis and secondary
necrosis converge on similar cellular disintegration features. Cell
Death Differ. 17:922–930. 2010. View Article : Google Scholar
|
|
48
|
Guzik K, Skret J, Smagur J, Bzowska M,
Gajkowska B, Scott DA and Potempa JS: Cigarette smoke-exposed
neutrophils die unconventionally but are rapidly phagocytosed by
macrophages. Cell Death Dis. 2:e1312011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pozarowski P, Halicka DH and Darzynkiewicz
Z: Cell cycle effects and caspase-dependent and independent death
of HL-60 and Jurkat cells treated with the inhibitor of NF-kappaB
parthenolide. Cell Cycle. 2:377–383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xia H, Zhang Z and You F: Inhibiting
ACSL1-related ferroptosis restrains murine coronavirus infection.
Viruses. 13:23832021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lin L, Zhang MX, Zhang L, Zhang D, Li C
and Li YL: Autophagy, pyroptosis, and ferroptosis: New regulatory
mechanisms for atherosclerosis. Front Cell Dev Biol. 9:8099552022.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee YS, Lee DH, Choudry HA, Bartlett DL
and Lee YJ: Ferroptosis-induced endoplasmic reticulum stress:
Cross-talk between ferroptosis and apoptosis. Mol Cancer Res.
16:1073–1076. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chu B, Kon N, Chen D, Li T, Liu T, Jiang
L, Song S, Tavana O and Gu W: ALOX12 is required for p53-mediated
tumour suppression through a distinct ferroptosis pathway. Nat Cell
Biol. 21:579–591. 2019. View Article : Google Scholar :
|
|
54
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zheng DW, Lei Q, Zhu JY, Fan JX, Li CX, Li
C, Xu Z, Cheng SX and Zhang XZ: Switching apoptosis to ferroptosis:
Metal-organic network for high-efficiency anticancer therapy. Nano
Lett. 17:284–291. 2017. View Article : Google Scholar
|
|
56
|
Rogers C, Erkes DA, Nardone A, Aplin AE,
Fernandes-Alnemri T and Alnemri ES: Gasdermin pores permeabilize
mitochondria to augment caspase-3 activation during apoptosis and
inflammasome activation. Nat Commun. 10:16892019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Newton K, Wickliffe KE, Dugger DL,
Maltzman A, Roose-Girma M, Dohse M, Kőműves L, Webster JD and Dixit
VM: Cleavage of RIPK1 by caspase-8 is crucial for limiting
apoptosis and necroptosis. Nature. 574:428–431. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li J, McQuade T, Siemer AB, Napetschnig J,
Moriwaki K, Hsiao YS, Damko E, Moquin D, Walz T, McDermott A, et
al: The RIP1/RIP3 necrosome forms a functional amyloid signaling
complex required for programmed necrosis. Cell. 150:339–350. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Icard P, Fournel L, Wu Z, Alifano M and
Lincet H: Interconnection between metabolism and cell cycle in
cancer. Trends Biochem Sci. 44:490–501. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Asghar U, Witkiewicz AK, Turner NC and
Knudsen ES: The history and future of targeting cyclin-dependent
kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ingham M and Schwartz GK: Cell-cycle
therapeutics come of age. J Clin Oncol. 35:2949–2959. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dulić V, Kaufmann WK, Wilson SJ, Tlsty TD,
Lees E, Harper JW, Elledge SJ and Reed SI: p53-dependent inhibition
of cyclin-dependent kinase activities in human fibroblasts during
radiation-induced G1 arrest. Cell. 76:1013–1023. 1994. View Article : Google Scholar
|
|
63
|
Akino K, Toyota M, Suzuki H, Imai T,
Maruyama R, Kusano M, Nishikawa N, Watanabe Y, Sasaki Y, Abe T, et
al: Identification of DFNA5 as a target of epigenetic inactivation
in gastric cancer. Cancer Sci. 98:88–95. 2007. View Article : Google Scholar
|
|
64
|
Kim MS, Chang X, Yamashita K, Nagpal JK,
Baek JH, Wu G, Trink B, Ratovitski EA, Mori M and Sidransky D:
Aberrant promoter methylation and tumor suppressive activity of the
DFNA5 gene in colorectal carcinoma. Oncogene. 27:3624–3634. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang CJ, Tang L, Shen DW, Wang C, Yuan QY,
Gao W, Wang YK, Xu RH and Zhang H: The expression and regulation of
DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular
carcinoma. Mol Biol Rep. 40:6525–6531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Van Laer L, Huizing EH, Verstreken M, van
Zuijlen D, Wauters JG, Bossuyt PJ, Van de Heyning P, McGuirt WT,
Smith RJ, Willems PJ, et al: Nonsyndromic hearing impairment is
associated with a mutation in DFNA5. Nat Genet. 20:194–197. 1998.
View Article : Google Scholar : PubMed/NCBI
|
